executive leadership

Sagimet Biosciences appoints Dr. Andreas Grauer as Chief Medical Officer, replacing retiring Dr. Eduardo Martins. Grauer joins from senior roles at Amgen and Corcept, receiving $1.34M in stock options.

Exponent promotes John Pye to President and Eric Anderson to CFO, with Rich Schlenker transitioning to Executive VP and board candidacy under CEO Catherine Corrigan.

Kratos Defense appoints aerospace veteran David King to board. King led Dynetics' threefold revenue growth before its $1.65B Leidos acquisition.

Portnoy Law Firm probes potential securities fraud at $GPK, examining whether board breached fiduciary duties amid recent executive leadership upheaval.

Absci appoints Vertex Pharma veteran Dr. Ransi Somaratne as Chief Medical Officer to lead clinical development of AI-designed therapeutics, signaling execution focus.

Chewy appoints Amazon finance executive Chris Deppe as new CFO. Stock rises 4.37% on announcement; Deppe brings 16 years of experience to strengthen financial operations.

Integer Holdings to present at three major healthcare investment conferences in March 2026, including Raymond James, Oppenheimer, and KeyBanc events.

FLSmidth appoints Qasim Abrahams as Products Business Line President, replacing departing Julian Soles. Alanas Kraujalis takes interim Service Business Line role.

Advantage Solutions will release Q4 2025 earnings March 3, 2026, with a conference call at 8:30 a.m. EDT. The company also announced executive leadership changes to boost growth.

Sinclair executives will present at two major finance conferences in March 2026, discussing strategic direction and financial performance with investors and analysts.